Physician profile
Robert Myles
NPI 1356349583
$4,708.37
in general payments reported to CMS, 2019-2025
30 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,799 · 2020: $428 · 2021: $70.45 · 2022: $298 · 2023: $327 · 2024: $1,496 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.39 |
| Travel and Lodging | $332.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,768.00 | 2019-2020 | |
| Arthrex, INC. | $765.24 | 2024 | |
| Providence Medical Technology, INC. | $459.51 | 2020-2024 | |
| Si-Bone, INC. | $234.79 | 2019-2025 | |
| Organogenesis INC. | $181.86 | 2020 | |
| Medtronic, INC. | $159.91 | 2021-2025 | O-Arm, Magnifuse Bone Graft, Mazor X System |
| Pylant Medical | $143.15 | 2023-2025 | |
| Cerapedics INC. | $98.77 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Baxter Healthcare | $89.31 | 2023-2025 | Floseal |
| Abbott Laboratories | $85.93 | 2019-2025 | Proclaim, Eterna |
| Stryker Corporation | $83.44 | 2022 | |
| Centinel Spine, LLC | $78.71 | 2024 | Prodisc C Vivo |
| Clariance, INC. | $77.16 | 2022 | |
| Ethicon US, LLC | $68.55 | 2019-2025 | Surgiflo Hemostatic Matrix |
| Cpm Medical Consultants, LLC | $54.27 | 2020-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $38.98 | 2020 | |
| Precision Spine, INC. | $38.75 | 2024 | |
| Intrinsic Therapeutics | $36.21 | 2020 | |
| Nuvasive, INC. | $36.09 | 2019 | |
| Bioventus LLC | $27.75 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Vertex Pharmaceuticals Incorporated | $25.59 | 2024 | |
| Innovation Technologies INC | $23.35 | 2024 | Irrisept |
| Spinal Simplicity, LLC | $19.55 | 2024 | Ha Minuteman G3-R |
| Azurity Pharmaceuticals, INC. | $18.73 | 2024 | Horizant |
| Avanos Medical | $18.31 | 2019 | |
| Arteriocyte Medical Systems, INC. | $17.20 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.60 | 2020 | |
| Kuros Biosciences USA, INC | $16.48 | 2025 | Magnetos |
| Smith+Nephew, INC. | $14.21 | 2020 | |
| Misonix INC | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Myles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.